Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved product, Ocaliva, is pulled off the market in the US and all trials of the ...

Ripples maintain time-locked occurrence across the septo-temporal axis and hemispheres while showing local phase coupling, revealing a dual mode of synchrony in CA1 network dynamics.

Across Asia, a new storytelling phenomenon has reshaped the way audiences watch and connect. The short-form drama model, which is comprised of ultra-short, serialized dramas designed for vertical ...

The Intercept dropped its most significant story in its three-year history on Tuesday. The website published a piece based on leaked NSA documents that detailed what appeared to be a previously ...

Anna Coren, CBS News foreign correspondent based in Hong Kong, is an Emmy Award-winning international correspondent who covers the Asia-Pacific region. East China Sea — Over the deep blue waters of ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

A federal judge in San Francisco on Wednesday temporarily blocked a federal administrative subpoena aimed at unmasking Instagram accounts that named and shamed a Border Patrol agent who was part of ...

There were six violations of a restricted airspace over Bedminster, New Jersey, while President Donald Trump was staying at his residence there over the weekend, the U.S. Air Force said. One of those ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...